The hereditary or acquired capacity of microbes around us and within us allows them to resist the action of antibiotics or antimicrobials on them. As a result, the microbes in their presence evolve and multiply. Microorganisms that develop resistance to more than one antimicrobial treatment are sometimes called "superbugs", and the mechanism of developing such resistance is called antimicrobial resistance. Because most antimicrobial compounds are produced from nature, antimicrobial resistance can evolve spontaneously; bacteria and fungi are known to develop defence mechanisms to withstand antimicrobial attacks and live, becoming antimicrobial-resistant. On the other hand, human activity plays a critical role in hastening this process and generating a global threat. Alarming rates of antibiotic resistance have been documented, and these rates continue to rise globally.
Based on estimates across multiple countries and territories, the most comprehensive estimates of the global impact of antibiotic resistance to date reveal that AMR has become a leading cause of death globally. Specific areas of concern equip governments and healthcare stakeholders, and communities with the information they need to act quickly and develop a proportionate response.
The AMR Industry Alliance was formed in 2017. With approximately 100 life sciences companies and trade associations, it represents nearly one-third of the sales volume and the majority of all novel products. Members have committed to report on activities they are undertaking in research & science, access to antibiotics and appropriate use of these, and responsible environmental manufacturing to tackle the rapid spread of antimicrobial resistance. If AMR remains unchecked, the annual death toll could climb from 700,000 each year to 10 million by 2050, and the economic impacts could be on par with those of the 2008 financial crisis. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Industry Declaration on AMR and the Roadmap for Progress on Combating AMR and measures progress made in the fight against AMR.
The organization has been supporting the initiatives being carried out by the AMR Industry Alliance for quite some time. On February 7th, 2022, Venus officially joined the alliance to participate in the biggest coalition of 100+ renowned global organizations that align with the AMR Industry Alliance's noble vision to develop solutions to combat the grave public health threat posed by Antimicrobial Resistance (AMR).
Welcoming Venus Remedies Limited as a new member, Melissa Mitchell, Secretariat Lead of AMR (antimicrobial resistance) Industry Alliance, said, "We are delighted to have Venus Remedies Limited join our ranks. As an organization, they lead by example and make commendable efforts to counter the threat of AMR by improving the access of AMR-relevant drugs to third-world countries, encouraging appropriate antibiotic use, and practical stewardship activities. Leading companies in the life science sector, like Venus Remedies Limited, are playing a vital role in the mitigation of AMR and continue to strengthen multi-stakeholder collaborations,"
The organization's participation in the AMR Industry Alliance adds life into the role of guaranteeing safe antibiotic manufacturing and availability as a part of the company's continued efforts to join forces with other organizations in a determined battle against AMR on a global scale.
"It is an honour to collaborate with the global life sciences industry under the aegis of the AMR Industry Alliance and devise sustainable solutions to AMR. We hope this association will amplify our existing efforts against AMR at a global level by shaping relevant AMR policies and plugging the leaks in the current antibiotic research and manufacturing landscape with a focus on access and appropriate use," Saransh Chaudhary, CEO | Venus Medicine Research Centre (VMRC), President | Global Critical Care, Venus Remedies Limited.
AMRIA, while consistently working on raising awareness and acting on AMR, has initiated various significant initiatives. One of the most important among them is World Antimicrobial Awareness Week, observed annually. Venus supported the initiative last year and is all geared up to do so this year as well!
World Antimicrobial Awareness Week is a global observance of events to encourage and enhance understanding and awareness around Antimicrobial Resistance. It is celebrated annually from November 18 to November 24.
The theme WAAW 2022 is "Preventing antimicrobial resistance together," announced jointly by:
The theme aims to unite organizations and people across sectors to preserve the efficacy of crucial medicines by understanding & encountering AMR. We need to work collectively for a One Health approach.
The first WAAW was observed in 2015, from November 16, 2015, to November 22, 2015. The campaign and other initiatives were launched in May 2015 at the sixty-eighth World Health Assembly (WHA). It called for a global action plan to curb AMR effectively and encourage the prudent use of antimicrobials. Hence, the slogan of WAAW is "Antimicrobials: Handle with Care." The antimicrobials are inclusive of antivirals, antibiotics, antifungals, and antiparasitics. The primary objective of the campaign is the promote the concept through effective communication, education, and training.
As last year, this year also, the World Health Organization will go for the "Go Blue" campaign, encouraging all (in any capacity - individual, organization, or community) to show support for the cause.
Besides this, many other activities are planned to fetch quality & relevant involvement and participation this year:
Venus would actively engage in WAAW 2022 and all other upcoming AMRIA initiatives with an endeavor to spread awareness among all & resist AMR by all means.
The Venus Remedies - AMRIA alliance aims to combat the impending threat and concerns of AntiMicrobial Resistance!
© All Rights Reserved | Privacy Policy | Adverse Drug Reaction
Venus Stands United with AMRIA To Combat AMR